Home > Drug Search >
  • company_query: Akinion
  •   > 
Drug Filter
Category:
chemistry (35) biology (3)
Status:
Approved (1) NDA Filing (1) Phase Ⅲ (2) Phase Ⅱ (15) Phase Ⅰ (19)
Clinical Stage:
Pending (7) Active (25) Discontinued (5)
Indication:
Acute liver damage caused by drug (1) Acute myeloid Leukemia (AML) (2) Alzheimer's disease (AD) (2) Amyotrophic lateral sclerosis (ALS) (1) Anxiety (1) Asthma (3) Attention deficit hyperactivity disorder (ADHD) (1) Basal cell carcinoma (BCC) (1) Breast cancer (2) Candidiasis (1) Chronic obstructive pulmonary disease (COPD) (2) Cutaneous fungal infections (1) Cystic fibrosis (CF) (1) Follicular lymphoma (1) Gastric cancer (1) Gastrointestinal stromal tumors (GISTs) (1) HCV infection (2) Hepatocellular carcinoma (HCC) (3) Septicaemia (1) Invasive aspergillosis (1) Lymphoma (3) Major depressive disorder (MDD) (2) Malignancies (1) Melanoma (1) Haematological disorders (1) Migraine (1) Multiple myeloma (MM) (3) Non small cell lung cancer (NSCLC) (2) Pancreatic cancer (2) Parkinson's disease (PD) (3) Prostate cancer (1) Solid tumours (6) Tourette's syndrome (1) Head and neck cancer (2) Colorectal cancer (1) Spondyloarthritis (1) Invasive fungal infection (1) Serious infections caused by Fusarium spp. (1) Dental infection (1) Gynecologic infection (1) Pain (1) Methicillin-resistant staphylococcus aureus infections (1) Malignant glioma (1) Biliary cancer (1) Diabetes (1) Renal carcinoma (1) Tibial fractures (1) Spondylolisthesis (1) Terminate pregnancy (1) Glioma (1) Refractory diffuse large B cell lymphoma (1) Diffuse large B cell lymphoma (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top